Special Issue "Candida auris 2.0"
A special issue of Journal of Fungi (ISSN 2309-608X).
Deadline for manuscript submissions: 1 November 2020.
Interests: candida; Candida auris; drug resistance fungal; emerging fungal diseases
Special Issues and Collections in MDPI journals
This year marks the 11th anniversary of the first formal description of Candida auris, isolated from the external ear of a Japanese patient in 2009. Retrospective studies of culture collections of yeasts from before 2009 only showed single isolates from Korea in 1996 (the earliest known isolate to date) and from Pakistan in 2008. In a relatively short period, C. auris was able to spread all over the world, mainly in hospitals, and has now been reported from six continents and more than 40 countries. Several countries have reported persistent problems and prolonged outbreaks in healthcare facilities. Unlike other Candida spp., C. auris seems to colonize the skin of patients and can contaminate hospital environments.
C. auris is easily transmitted in healthcare settings and is the first fungus to behave like an epidemic nosocomial bacterial pathogen. Transmission within and between hospitals and nursing home facilities confronts us with major infection control challenges, prompting authorities in the US to declare colonization or infection with C. auris as a notifiable disease from 2019 onwards. More than 90% of C. auris isolates are fluconazole resistant, with some rare isolates also being resistant to all three major antifungal classes, leaving no possible treatment options. A major explanation for the quick worldwide spread was that C. auris is often misidentified as other Candida spp., notably C. haemulonii, or as Saccharomyces when identification methods based on phenotype are used. Manufacturers are now working to solve this problem of routine identification, though molecular methods or MALDI-TOF can reliably identify C. auris. We invite you to consider submitting the results of your latest original studies or clinical cases involving this special pathogen, C. auris, to this Special Issue of the Journal of Fungi.
Prof. Dr. Jacques F. Meis
Prof. Dr. Anuradha Chowdhary
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Candida auris
- drug-resistant fungi
- infection control
- emerging fungal diseases